MedTrace Logo

Evaluation of the EpiGlare Tester for the Measurement of Glare-Induced Changes in BSCVA in Subjects With and Without Cataracts

NCT04739397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2021-02-04

No results posted yet for this study

Summary

The EpiGlare Tester will identify visual disability resulting from the glare experienced by subjects with cataracts in the glare-induced change in best spectacle corrected visual acuity (BSCVA).

Conditions

  • Cataract

Interventions

DEVICE

Glare Testing

Vision in Cataract patients were tested with and without the EpiGlare Tester

Sponsors & Collaborators

  • Epico, LLC

    lead INDUSTRY

Principal Investigators

  • Nicole R Fram, MD · Advanced Vision Care

  • Samuel Masket, MD · Advanced Vision Care

  • Fancis W Price, MD · Price Vision Group

  • R. Doyle Stulting, MD, PhD · Woolfson Eye Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-11-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04739397 on ClinicalTrials.gov